Can a Pharmacist's help turn the tide against a deadly lung disease?
NCT ID NCT07457762
Summary
This study is testing whether having a pharmacist provide support and education can help people with pulmonary arterial hypertension (PAH) stick to their prescribed inhaled medication. PAH is a serious lung condition where survival is often limited. The research will see if this extra support improves how well patients follow their treatment plan and manage side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Incor HCFMUSP
RECRUITINGSão Paulo, São Paulo, 01246-000, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.